Synthetic data in machine learning for medicine and healthcare.
Ontology highlight
ABSTRACT:
SUBMITTER: Chen RJ
PROVIDER: S-EPMC9353344 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
Publications
Synthetic data in machine learning for medicine and healthcare.
Chen Richard J RJ Lu Ming Y MY Chen Tiffany Y TY Williamson Drew F K DFK Mahmood Faisal F
Nature biomedical engineering 20210601 6
Similar Datasets
Project description:There is a growing demand for the uptake of modern artificial intelligence technologies within healthcare systems. Many of these technologies exploit historical patient health data to build powerful predictive models that can be used to improve diagnosis and understanding of disease. However, there are many issues concerning patient privacy that need to be accounted for in order to enable this data to be better harnessed by all sectors. One approach that could offer a method of circumventing privacy issues is the creation of realistic synthetic data sets that capture as many of the complexities of the original data set (distributions, non-linear relationships, and noise) but that does not actually include any real patient data. While previous research has explored models for generating synthetic data sets, here we explore the integration of resampling, probabilistic graphical modelling, latent variable identification, and outlier analysis for producing realistic synthetic data based on UK primary care patient data. In particular, we focus on handling missingness, complex interactions between variables, and the resulting sensitivity analysis statistics from machine learning classifiers, while quantifying the risks of patient re-identification from synthetic datapoints. We show that, through our approach of integrating outlier analysis with graphical modelling and resampling, we can achieve synthetic data sets that are not significantly different from original ground truth data in terms of feature distributions, feature dependencies, and sensitivity analysis statistics when inferring machine learning classifiers. What is more, the risk of generating synthetic data that is identical or very similar to real patients is shown to be low.
| S-EPMC7653933 | biostudies-literature
Project description:This SuperSeries is composed of the SubSeries listed below.
2017-12-13 | GSE108004 | GEO
Project description:We demonstrate a promising approach to identify robust molecular markers for targeted treatment of acute myeloid leukemia. We show that our method outperforms several state-of-the-art approaches in identifying molecular markers replicated in validation data and predicting drug sensitivity accurately. Finally, we identify SMARCA4 as a marker and driver of sensitivity to topoisomerase II inhibitors, mitoxantrone and etoposide, in AML by showing that cell lines transduced to have high SMARCA4 expression reveal dramatically increased sensitivity to these agents.
2017-11-30 | GSE107465 | GEO
Project description:Human feelings are fundamental to perceive the conduct and state of mind of an individual. A healthy emotional state is one significant highlight to improve personal satisfaction. On the other hand, bad emotional health can prompt social or psychological well-being issues. Recognizing or detecting feelings in online health care data gives important and helpful information regarding the emotional state of patients. To recognize or detection of patient's emotion against a specific disease using text from online sources is a challenging task. In this paper, we propose a method for the automatic detection of patient's emotions in healthcare data using supervised machine learning approaches. For this purpose, we created a new dataset named EmoHD, comprising of 4,202 text samples against eight disease classes and six emotion classes, gathered from different online resources. We used six different supervised machine learning models based on different feature engineering techniques. We also performed a detailed comparison of the chosen six machine learning algorithms using different feature vectors on our dataset. We achieved the highest 87% accuracy using MultiLayer Perceptron as compared to other state of the art models. Moreover, we use the emotional guidance scale to show that there is a link between negative emotion and psychological health issues. Our proposed work will be helpful to automatically detect a patient's emotion during disease and to avoid extreme acts like suicide, mental disorders, or psychological health issues. The implementation details are made publicly available at the given link: https://bit.ly/2NQeGET.
| S-EPMC8725656 | biostudies-literature
Project description:Spurred by advances in processing power, memory, storage, and an unprecedented wealth of data, computers are being asked to tackle increasingly complex learning tasks, often with astonishing success. Computers have now mastered a popular variant of poker, learned the laws of physics from experimental data, and become experts in video games - tasks that would have been deemed impossible not too long ago. In parallel, the number of companies centered on applying complex data analysis to varying industries has exploded, and it is thus unsurprising that some analytic companies are turning attention to problems in health care. The purpose of this review is to explore what problems in medicine might benefit from such learning approaches and use examples from the literature to introduce basic concepts in machine learning. It is important to note that seemingly large enough medical data sets and adequate learning algorithms have been available for many decades, and yet, although there are thousands of papers applying machine learning algorithms to medical data, very few have contributed meaningfully to clinical care. This lack of impact stands in stark contrast to the enormous relevance of machine learning to many other industries. Thus, part of my effort will be to identify what obstacles there may be to changing the practice of medicine through statistical learning approaches, and discuss how these might be overcome.
| S-EPMC5831252 | biostudies-literature
Project description:We demonstrate a promising approach to identify robust molecular markers for targeted treatment of acute myeloid leukemia. We show that our method outperforms several state-of-the-art approaches in identifying molecular markers replicated in validation data and predicting drug sensitivity accurately. Finally, we identify SMARCA4 as a marker and driver of sensitivity to topoisomerase II inhibitors, mitoxantrone and etoposide, in AML by showing that cell lines transduced to have high SMARCA4 expression reveal dramatically increased sensitivity to these agents.
2017-12-13 | GSE108003 | GEO
Project description:The ecological effects of accidental or malicious radioactive contamination are insufficiently understood because of the hazards and difficulties associated with conducting studies in radioactively-polluted areas. Data sets from severely contaminated locations can therefore be small. Moreover, many potentially important factors, such as soil concentrations of toxic chemicals, pH, and temperature, can be correlated with radiation levels and with each other. In such situations, commonly-used statistical techniques like generalized linear models (GLMs) may not be able to provide useful information about how radiation and/or these other variables affect the outcome (e.g. abundance of the studied organisms). Ensemble machine learning methods such as random forests offer powerful alternatives. We propose that analysis of small radioecological data sets by GLMs and/or machine learning can be made more informative by using the following techniques: (1) adding synthetic noise variables to provide benchmarks for distinguishing the performances of valuable predictors from irrelevant ones; (2) adding noise directly to the predictors and/or to the outcome to test the robustness of analysis results against random data fluctuations; (3) adding artificial effects to selected predictors to test the sensitivity of the analysis methods in detecting predictor effects; (4) running a selected machine learning method multiple times (with different random-number seeds) to test the robustness of the detected "signal"; (5) using several machine learning methods to test the "signal's" sensitivity to differences in analysis techniques. Here, we applied these approaches to simulated data, and to two published examples of small radioecological data sets: (I) counts of fungal taxa in samples of soil contaminated by the Chernobyl nuclear power plan accident (Ukraine), and (II) bacterial abundance in soil samples under a ruptured nuclear waste storage tank (USA). We show that the proposed techniques were advantageous compared with the methodology used in the original publications where the data sets were presented. Specifically, our approach identified a negative effect of radioactive contamination in data set I, and suggested that in data set II stable chromium could have been a stronger limiting factor for bacterial abundance than the radionuclides 137Cs and 99Tc. This new information, which was extracted from these data sets using the proposed techniques, can potentially enhance the design of radioactive waste bioremediation.
| S-EPMC5222373 | biostudies-literature
Project description:Precision medicine is one of the recent and powerful developments in medical care, which has the potential to improve the traditional symptom-driven practice of medicine, allowing earlier interventions using advanced diagnostics and tailoring better and economically personalized treatments. Identifying the best pathway to personalized and population medicine involves the ability to analyze comprehensive patient information together with broader aspects to monitor and distinguish between sick and relatively healthy people, which will lead to a better understanding of biological indicators that can signal shifts in health. While the complexities of disease at the individual level have made it difficult to utilize healthcare information in clinical decision-making, some of the existing constraints have been greatly minimized by technological advancements. To implement effective precision medicine with enhanced ability to positively impact patient outcomes and provide real-time decision support, it is important to harness the power of electronic health records by integrating disparate data sources and discovering patient-specific patterns of disease progression. Useful analytic tools, technologies, databases, and approaches are required to augment networking and interoperability of clinical, laboratory and public health systems, as well as addressing ethical and social issues related to the privacy and protection of healthcare data with effective balance. Developing multifunctional machine learning platforms for clinical data extraction, aggregation, management and analysis can support clinicians by efficiently stratifying subjects to understand specific scenarios and optimize decision-making. Implementation of artificial intelligence in healthcare is a compelling vision that has the potential in leading to the significant improvements for achieving the goals of providing real-time, better personalized and population medicine at lower costs. In this study, we focused on analyzing and discussing various published artificial intelligence and machine learning solutions, approaches and perspectives, aiming to advance academic solutions in paving the way for a new data-centric era of discovery in healthcare.
| S-EPMC7078068 | biostudies-literature
Project description:When enabled by machine learning (ML), Learning Health Systems (LHS) hold promise for improving the effectiveness of healthcare delivery to patients. One major barrier to LHS research and development is the lack of access to EHR patient data. To overcome this challenge, this study demonstrated the feasibility of developing a simulated ML-enabled LHS using synthetic patient data. The ML-enabled LHS was initialized using a dataset of 30,000 synthetic Synthea patients and a risk prediction XGBoost base model for lung cancer. 4 additional datasets of 30,000 patients were generated and added to the previous updated dataset sequentially to simulate addition of new patients, resulting in datasets of 60,000, 90,000, 120,000 and 150,000 patients. New XGBoost models were built in each instance, and performance improved with data size increase, attaining 0.936 recall and 0.962 AUC (area under curve) in the 150,000 patients dataset. The effectiveness of the new ML-enabled LHS process was verified by implementing XGBoost models for stroke risk prediction on the same Synthea patient populations. By making the ML code and synthetic patient data publicly available for testing and training, this first synthetic LHS process paves the way for more researchers to start developing LHS with real patient data.
| S-EPMC9606301 | biostudies-literature
Project description:Alzheimer's disease (AD) is a serious neurodegenerative disorder that causes incurable and irreversible neuronal loss and synaptic dysfunction. The progress of this disease is gradual and depending on the stage of its detection, only its progression can be treated, reducing the most aggressive symptoms and the speed of its neurodegenerative progress. This article proposes an early detection model for the diagnosis of AD by performing analyses in Alzheimer's progression patient datasets, provided by the Alzheimer's Disease Neuroimaging Initiative (ADNI), including only neuropsychological assessments and making use of feature selection techniques and machine learning models. The focus of this research is to build an ensemble machine learning model capable of early detection of a patient with Alzheimer's or a cognitive state that leads to it, based on their results in neuropsychological assessments identified as highly relevant for the detection of Alzheimer's. The proposed approach for the detection of AD is presented with the inclusion of the feature selection technique recursive feature elimination (RFE) and the Akaike Information Criterion (AIC), the ensemble model consists of logistic regression (LR), artificial neural networks (ANN), support vector machines (SVM), K-nearest neighbors (KNN) and nearest centroid (Nearcent). The datasets downloaded from ADNI were divided into 13 subsets including: cognitively normal (CN) vs subjective memory concern (SMC), CN vs early mild cognitive impairment (EMCI), CN vs late mild cognitive impairment (LMCI), CN vs AD, SMC vs EMCI, SMC vs LMCI, SMC vs AD, EMCI vs LMCI, EMCI vs AD, LMCI vs AD, MCI vs AD, CN vs AD and CN vs MCI. From all the feature results, a custom model was created using RFE, AIC and testing each model. This work presents a customized model for a backend platform to perform one-versus-all analysis and provide a basis for early diagnosis of Alzheimer's at its current stage.
| S-EPMC11784714 | biostudies-literature